OPK (OPKO Health) Long-Term Debt: $336.0 Mil (As of Mar. 2026)


OPK OPKO Health Inc OPK
56 GF Score
Price $1.52
GF Value $1.06
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is OPKO Health Long-Term Debt?

OPKO Health OPK 56 Long-Term Debt is $336.0 Mil as of Mar. 2026. GuruFocus rates OPK with a GF Score™ of 56/100 and a GF Value™ of $1.06 (Significantly Overvalued). The stock has 7 warning signs investors should review.

OPKO Health's Long-Term Debt for the quarter that ended in Mar. 2026 was $336.0 Mil.

OPKO Health's quarterly Long-Term Debt increased from Sep. 2025 ($331.4 Mil) to Dec. 2025 ($333.7 Mil) and increased from Dec. 2025 ($333.7 Mil) to Mar. 2026 ($336.0 Mil).

OPKO Health's annual Long-Term Debt increased from Dec. 2023 ($222.0 Mil) to Dec. 2024 ($422.2 Mil) but then declined from Dec. 2024 ($422.2 Mil) to Dec. 2025 ($333.7 Mil).

OPKO Health  (NAS:OPK) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

OPKO Health Long-Term Debt Related Terms

OPKO Health Long-Term Debt Historical Data

* Premium members only.

The historical data trend for OPKO Health's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OPKO Health Long-Term Debt Chart

OPKO Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 190.16 219.47 222.03 422.18 333.72

OPKO Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 325.85 329.25 331.43 333.72 336.03
OPK
56GF Score
OPKO Health Inc OPK
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $336.0 Mil mean?
OPKO Health (OPK) has a Long-Term Debt of $336.0 Mil as of Mar. 2026.
Is OPKO Health's Long-Term Debt too high?
OPKO Health's current Long-Term Debt is $336.0 Mil. Overall, OPKO Health has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does OPKO Health's Long-Term Debt compare to PSNL and CDNA?
OPKO Health's Long-Term Debt of $336.0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Diagnostics & Research company?
A good Long-Term Debt depends on the Medical Diagnostics & Research industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. OPKO Health's current Long-Term Debt is $336.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OPKO Health stock overvalued right now?
Based on GuruFocus' analysis, OPKO Health (OPK) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.06, compared to a current price of $1.52 — trading 43.4% above its estimated fair value. The current Long-Term Debt is $336.0 Mil. OPKO Health's overall GF Score™ is 56/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For OPKO Health (OPK), the current Long-Term Debt is $336.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OPKO Health (OPK) Overvalued in 2026?

Based on GuruFocus' analysis, OPKO Health stock appears to be overvalued. The current stock price of $1.52 is trading 43.4% above its estimated GF Value™ of $1.06. GuruFocus considers OPKO Health to be Significantly Overvalued.

Key valuation signals for OPK:

  • Long-Term Debt: $336.0 Mil
  • GF Value™: $1.06 vs. price of $1.52 (43.4% above fair value)
  • GF Score™: 56/100 with 7 warning signs

No single metric tells the full story. See the OPK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OPKO Health Business Description

Address 4400 Biscayne Boulevard, Miami, FL, USA, 33137
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
56GF Score

Get the complete analysis for OPK

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.52
Price
$1.06
GF Value